Codiak BioSciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Codiak BioSciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 22.52K shares, a 15.30% decline year-over-year.
- Codiak BioSciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 88.33K shares.
- Codiak BioSciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 276.09K shares.
- Codiak BioSciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 46.81K shares.
- Codiak BioSciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 433.75K shares, a 811.39% increase from fiscal 2020.
- Codiak BioSciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 47.59K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-12-31 | 22.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 433.75K shares 10-K · filed 2022-03-10 |
| 2021-09-30 | 88.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 437.82K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 276.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | |
| 2021-03-31 | 46.81K shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 26.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 47.59K shares 10-K · filed 2021-03-17 |